Osteoclasts are multinucleated giant cells that resorb bone, ensuring development and continuous remodelling of the skeleton and the bone marrow haematopoietic niche. Defective osteoclast activity leads to osteopetrosis and bone marrow failure [1] [2] [3] [4] [5] [6] [7] [8] [9] , whereas excess activity can contribute to bone loss and osteoporosis 10 . Osteopetrosis can be partially treated by bone marrow transplantation in humans and mice [11] [12] [13] [14] [15] [16] [17] [18] , consistent with a haematopoietic origin of osteoclasts 13, 16, 19 and studies that suggest that they develop by fusion of monocytic precursors derived from haematopoietic stem cells in the presence of CSF1 and RANK ligand 1, 20 . However, the developmental origin and lifespan of osteoclasts, and the mechanisms that ensure maintenance of osteoclast function throughout life in vivo remain largely unexplored. Here we report that osteoclasts that colonize fetal ossification centres originate from embryonic erythro-myeloid progenitors 21,22 . These erythromyeloid progenitor-derived osteoclasts are required for normal bone development and tooth eruption. Yet, timely transfusion of haematopoietic-stem-cell-derived monocytic cells in newborn mice is sufficient to rescue bone development in early-onset autosomal recessive osteopetrosis. We also found that the postnatal maintenance of osteoclasts, bone mass and the bone marrow cavity involve iterative fusion of circulating blood monocytic cells with long-lived osteoclast syncytia. As a consequence, parabiosis or transfusion of monocytic cells results in long-term gene transfer in osteoclasts in the absence of haematopoietic-stem-cell chimerism, and can rescue an adult-onset osteopetrotic phenotype caused by cathepsin K deficiency 23,24 . In sum, our results identify the developmental origin of osteoclasts and a mechanism that controls their maintenance in bones after birth. These data suggest strategies to rescue osteoclast deficiency in osteopetrosis and to modulate osteoclast activity in vivo.
. Osteopetrosis can be partially treated by bone marrow transplantation in humans and mice [11] [12] [13] [14] [15] [16] [17] [18] , consistent with a haematopoietic origin of osteoclasts 13, 16, 19 and studies that suggest that they develop by fusion of monocytic precursors derived from haematopoietic stem cells in the presence of CSF1 and RANK ligand 1, 20 . However, the developmental origin and lifespan of osteoclasts, and the mechanisms that ensure maintenance of osteoclast function throughout life in vivo remain largely unexplored. Here we report that osteoclasts that colonize fetal ossification centres originate from embryonic erythro-myeloid progenitors 21, 22 . These erythromyeloid progenitor-derived osteoclasts are required for normal bone development and tooth eruption. Yet, timely transfusion of haematopoietic-stem-cell-derived monocytic cells in newborn mice is sufficient to rescue bone development in early-onset autosomal recessive osteopetrosis. We also found that the postnatal maintenance of osteoclasts, bone mass and the bone marrow cavity involve iterative fusion of circulating blood monocytic cells with long-lived osteoclast syncytia. As a consequence, parabiosis or transfusion of monocytic cells results in long-term gene transfer in osteoclasts in the absence of haematopoietic-stem-cell chimerism, and can rescue an adult-onset osteopetrotic phenotype caused by cathepsin K deficiency 23, 24 . In sum, our results identify the developmental origin of osteoclasts and a mechanism that controls their maintenance in bones after birth. These data suggest strategies to rescue osteoclast deficiency in osteopetrosis and to modulate osteoclast activity in vivo.
In vitro, osteoclasts arise by fusion of haematopoietic stem cell (HSC)-derived precursors and require expression of Csf1r and Tnfrsf11a (also known as Rank). To probe the origin of osteoclasts in vivo we first generated Csf1r cre ;Csf1r fl/fl and Csf1r cre ;Tnfrsf11a fl/fl mice. These mice presented with an osteopetrotic phenotype similar to Csf1 op/op (ref. 5 ), Csf1r 6 and Tnfrsf11a 3 mutants, characterized in young mice by a lack of teeth eruption, skull and skeletal deformities with shortness of long bones, increased bone density and lack of osteoclasts and haematopoietic cells (Fig. 1a, Extended Data Fig. 1 ). To confirm that osteoclast differentiation requires expression of Tnfrsf11a and Csf1r in HSCderived precursors, we generated (Fig. 1d) , and by 22-60 weeks of age had increased trabecular bone density (Fig. 1e ) and decreased haematopoietic cell numbers in the long bones (Fig. 1c, Extended Data Fig. 2) , and 3D X-ray imaging by micro-computed tomography (micro-CT) confirmed the increased bone mass, whereas bone formationmeasured by calcein incorporation-was similar to that in control mice ( These data suggested that although postnatal contribution of HSC-derived cells is important for optimal osteoclast maintenance and function in adults and ageing mice, osteoclast development, tooth eruption and the development of bone and the bone marrow cavity require precursors that are independent from the HSC lineage. These precursors may originate from the embryonic erythro-myeloid progenitor (EMP) lineage of resident macrophages 22, 26, 27 , because Csf1r cre mice enable deletion of target genes in both the embryonic EMP lineage and in the HSC lineage, whereas Flt3 cre (refs 22,26 ) and Vav cre (Extended Data Fig. 5 ) are not expressed in the EMP lineage. In support of this hypothesis, we found that TRAP + multinucleated cells develop in ossification centres from Myb-deficient embryos around E15; at this stage the embryos lack HSCs but still support the development of EMP-derived macrophages 26 ( Fig. 2a, b ). In addition, TRAP + multinucleated cells are labelled with YFP in tamoxifen-inducible Csf1r
Mer-icre-Mer ;Rosa26 LSL-YFP mice pulsed at E8.5 with a single dose of hydroxytamoxifen (4-OHT), which labels EMPs but not HSCs 22, 26, 27 ( Fig. 2c, d , Extended Data Fig. 4 ). Together, these results indicate that fetal osteoclasts arise from EMPs in ossification centres.
We therefore investigated whether EMPs are required for bone development. Tnfrsf11a is expressed by osteoclasts, but its expression is also a hallmark of EMP-derived macrophage precursors that colonize the developing embryo 27 . In two independent lines of Tnfrsf11a cre knock-in mice, referred to as 'Koba' and 'Wask' (Fig. 2e-j Fig. 2 ). They exhibited a severe osteopetrotic phenotype, including a lack of tooth eruption (Fig. 2e) , misshaped skulls and shorter long bones (Fig. 2 f-h, Extended Data Fig. 1 ) with few osteoclasts (Fig. 2i) and increased bone density, and initially lacked a bone marrow cavity (Fig. 2f, Extended Data Fig. 2) . In contrast to Csf1r-deficient mice, however, osteoclasts and haematopoietic cells progressively colonized the long bones of Tnfrsf11a cre ;Csf1r fl/fl mice during the first month of life (Fig. 2i, Extended Data Figs. 1, 2) , although the mice remained toothless and skull and long-bone deformity persisted (Fig. 2e-h, Extended Data Fig. 1 Data Fig. 6 ). In a complementary approach, ablation of Csf1r expression in E10.5 embryos using a single dose of tamoxifen in Rosa26-creER T2+ 
;Csf1r
fl/− mice resulted in defective tooth eruption in 3 out of 4 pups at 21 days of age (Extended Data Fig. 5 ). Together, these analyses support a model in which EMP-derived embryonic osteoclasts are needed for teeth eruption, normal skull shape, optimal formation of long bones and the timely colonization of long bones by haematopoietic progenitors, whereas HSC-derived osteoclasts are important for the maintenance of bone mass after birth and later in life, although they may partially rescue bone development in the absence of EMP-derived osteoclasts in Tnfrsf11a cre ;Csf1r fl/fl mice. To probe the mechanisms that underlie the contribution of HSCderived blood cells to osteoclast maintenance as well as the lifespan and dynamics of osteoclasts in vivo, we performed time-course parabiosis experiments (Fig. 3a) . After four-to-eight weeks of shared blood circulation between Csf1r cre ;Rosa26
LSL-YFP and Csf1r cre ;Rosa26
LSL-tdTomato
parabionts, all osteoclasts-defined as TRAP + multinucleated cells lining the bone surface-expressed both YFP and tdTomato (Fig. 3a, b) . No other cell type was found to co-express YFP and tdTomato in bones cre ;Rosa26 LSL-YFP mice at E16.5, E18.5, P7, 4 weeks (4 w), 3 months (3 m) and 6 months (6 m). Data are mean ± s.d.; dots in graphs represent individual independent biological replicates; n indicates the number of mice per group. Statistical significance was analysed with GraphPad Prism using unpaired two-tailed t-tests unless otherwise indicated. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001.
Letter reSeArCH (Fig. 3b) . This is consistent with the presence of nuclei from both partners in individual osteoclasts. Moreover, when parabionts were separated after 4 weeks (Fig. 3c) , most recipient YFP + osteoclasts retained tdTomato staining 14 weeks after separation, and 2/3 of osteoclasts from former parabionts still expressed both YFP and tdTomato 24 weeks after separation (Fig. 3c) . tdTomato signal intensity per YFP osteoclast increased during the eight-week period of shared blood circulation, and decreased after separation (Extended Data Fig. 7 ). Most mouse osteoclasts contained around five (range from three to seven) nuclei, with a modest increase of nuclei number per cell between one and six months of age (Fig. 3d) . These data therefore suggest that individual osteoclast syncytia are long-lived, but acquire new nuclei one at a time every four to eight weeks, from circulating blood cells; it therefore takes more than six months to renew all five nuclei in an individual osteoclast.
We calculated the number and fusion rate of HSC-derived nuclei acquired by osteoclasts in short-term 5-ethynyl-2′-deoxyuridine (EdU)-incorporation studies. A single intravenous pulse of EdU (20 μg g −1 ) labelled mitotic nuclei and was bioavailable in the bone marrow for around 90 min; approximately 50% of bone marrow and blood monocytic cells were EdU + for around 48 h (Extended Data  Fig. 7) . We observed that approximately 1-2% of osteoclasts were labelled after 72 h, with only 1 EdU + nucleus per osteoclast in 90% of EdU + cells (Fig. 3e) , which suggests that osteoclasts acquire a single postmitotic nucleus at a time. In this model, 0.5-2% of osteoclasts per day acquire a new nucleus, compatible with individual nuclei being Mer-icre-Mer ;Rosa26 LSL-YFP mice (n = 8) and Cre-negative controls (n = 5), pulsed at E8.5 with 4-OHT. d, Representative confocal microscopy of a sample from c. Scale bar, 100 μm. e, Representative teeth of Cre + Tnfrsf11a Koba-cre ;Csf1r fl/fl (top) and Tnfrsf11a
Wask-cre ;Csf1r fl/− mice (bottom) and Cre − control littermates. f, Leg bones from Tnfrsf11a cre ;Csf1r fl/fl mice (Cre + , n = 6) and control littermates (Cre − , n = 6) at P7 and 4 weeks of age. Arrowhead highlights the colour of an area of bone. Scale bar, 200 μm. g, Representative micro-CT scans of long bones from mice in e (n = 6 per genotype). h, Skull length from three-week-old Csf1r −/− (n = 6) control littermates (n = 12) and Tnfrsf11a
Wask-cre ;Csf1r fl/− mice (n = 4), as determined by micro-CT. i, Osteoclast counts in bone sections from E18.5, P7 and three-to-four-week old Tnfrsf11a cre ;Csf1r fl/fl mice and littermate controls. j, Number of bone marrow CD45 + cells determined by flow cytometry of cells from four-week-old control (Cre − ) littermates, Tnfrsf11a Koba-cre ; Csf1r fl/fl (n = 9; n = 13 control) and Tnfrsf11a Wask-cre ;Csf1r fl/− (n = 23, n = 27 control) mice (Cre + ). Data are mean ± s.d.; dots in graphs represent individual mice; n indicates the number of mice per group; unpaired two-tailed t-tests. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001. Letter reSeArCH replaced about every 2 months. Together, these studies suggest a model ( Fig. 3f ) in which osteoclasts that control skeletal development mature in ossification centres from EMPs, whereas their postnatal maintenance is mediated by the serial acquisition by long-lived syncytia of new nuclei from HSC-derived blood leukocytes, rather than by de novo renewal by lateral fusion or proliferation of osteoclast precursors.
A prediction from this model-consistent with an early observation 29 -is that osteopetrosis due to a recessive mutation that affects osteoclast function may be rescued or prevented through parabiosis with a wild-type partner. Parabiosis experiments between four-weekold cathepsin K-deficient mice, which develop an adult-onset form of osteopetrosis known as pycnodysostosis 23, 24 , and cathepsin K +/− or cathepsin K −/− littermates, and between wild-type mice as control, showed a reduction of bone volume in ten-week-old cathepsin K −/− mice paired with cathepsin K +/− littermates (Fig. 4a) , which suggests that circulating blood cells that carry a wild-type cathepsin K allele are sufficient to reduce bone density. To confirm that expression of a donor-derived gene by recipient osteoclasts results from fusion with monocytic cells circulating in the blood, we performed intravenous injections of KIT
−

Ly6C
+ cells from the bone marrow of Csf1r cre ;Rosa26 LSL-tdTomato mice into Csf1r cre ;Rosa26 LSL-YFP recipients (Fig. 4b, Extended Data Fig. 8 ). This resulted in stable expression of tdTomato in 20-40% of osteoclasts 1 week and 8 weeks after transfusion, in the absence of other donor-derived blood cells or bone marrow progenitors (Fig. 4b, c, Extended Data Fig. 8 ). These results suggest that parabiosis or an appropriate transfusion protocol can achieve expression of a donor-derived gene by recipient osteoclasts in the absence of HSC chimerism, and that this effect can last several months. ;Csf1r F/F neonates, starting from postnatal day (P)5, resulted in complete or partial rescue of teeth eruption ( Fig. 4d) and long-bone development as assessed by computerized tomography (CT) scan, with the development of a bone marrow cavity (Fig. 4d ) at day 14 in infant mice from three different litters (Fig. 4d,  Extended Data Fig. 9 ). In these mice, femur histology indicated the presence of numerous YFP + TRAP + osteoclasts lining the bone (Fig. 4e, f) . Histology and flow cytometry analyses showed the lack of YFP + circulating blood cells or bone marrow progenitors (Fig. 4e, g ), indicating the absence of HSC engraftment. These data suggest that transfusion of monocytic cells can rescue bone development in early-onset autosomal recessive osteopetrosis in infant mice, in the absence of HSC transplantation.
In sum, we have shown here that osteoclasts originating from EMPs are essential for normal bone development. Moreover, we show that osteoclasts are long-lived in adults and that their function is maintained by iterative fusion of individual HSC-derived circulating cells with existing syncytia. With absence or deficiency of EMP-derived osteoclasts, however, their timely replacement by transfusion with monocytic cells can rescue bone development in early-onset osteopetrotic mice without bone marrow transplantation. This is of potential clinical relevance because bone marrow and HSC transplantation, the standard treatment for early-onset osteopetrosis in mice and humans [11] [12] [13] [14] [15] [16] [17] [18] , requires irradiation or chemotherapy-which increases the risk of infections, is frequently performed in patients who already suffer severe complications and has a six-year overall survival rate of approximately 48% 17 . In addition, the original mechanism that mediates osteoclast Letter reSeArCH maintenance in adult mice suggests that these cells represent a unique target for gene transfer by cellular therapies based on transfusion of wild-type or engineered monocytic cells to modulate osteoclast activity and bone remodelling in adults.
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; stock number 007908) reporter mice were purchased from The Jackson Laboratory. Animal procedures. Mice were bred and kept under specific pathogen conditions in separated ventilated cages in the animal facility of MSKCC and the Medical Theoretical Center of the TU Dresden. All experiments with osteopetrotic mice that lack teeth were performed with mice maximal four weeks of age that were kept with the lactating mother or provided with DietGel 76A (Clear H 2 O, 72-07-5022) to avoid secondary effects from malnutrition. Experiments were performed in adherence to the Institutional Review Board (IACUC 15-04-006) from MSKCC and Landesdirektion Dresden and were in compliance with relevant ethical regulations. Mice greater than seven days old were killed by cervical dislocation (TU Dresden), CO 2 asphyxiation or anaesthesia (MSKCC). To collect embryos, pregnant females were euthanized and embryos were collected by postmortem caesarean from the uterus and exsanguinated through decapitation in cold PBS (Fisher, 14190). Genotyping. PCR genotyping was performed according to protocols that have previously been described 6,30-37,39-41 and indicated in Supplementary Table 1 . The investigators were not blinded to allocation during experiments and outcome assessment. Fate mapping with tamoxifen-inducible Cre models. For timing of embryonic development, mice were crossed at night, the following day a positive vaginal plug was considered as 0.5 days postcoitum (dpc), as previously described 22, 26 . Embryos were collected as indicated below. For postnatal time point, pregnant females were monitored for the date of delivery, caesarean sections were carried out at term and neonates were fostered using lactating CD-1 females.
Csf1r Mer-icre-Mer female mice were crossed with male Rosa26 LSL-YFP/LSL-YFP mice. Cre recombination in Csf1r
Mer-icre-Mer ;Rosa26 LSL-YFP embryos at E8.5 was induced with a single dose of 4-OHT injected intraperitoneally in pregnant mothers at a dose of 75 μg/g of body weight supplemented with 37.5 μg/g of progesterone as previously described 14 . Cre-mediated recombination in Rosa26-creER T2 was introduced to pregnant mothers by a single tamoxifen gavage (5 mg) at E10.5, supplemented with progesterone (37.5 μg/g body weight resolved in sunflower seed oil (Sigma-Aldrich)), injected intraperitoneally directly after gavage. To analyse newborn or three-week-old mice, caesarean sections were carried out at term and neonates were fostered using lactating CD-1 females. LSL-tdTomato females were used for parabiosis. For rescue of cathepsin K activity, four-week-old female Ctsk cre/cre and control littermate mice were used for parabiosis. Parabionts were kept on sulfamethoxazole/trimethoprim (Sulfatrim) diet for up to eight weeks. Ex-parabionts were separated after four weeks for cellular complementation and six weeks for rescue of cathepsin K activity. Surgical procedure, pre-operative procedure. Weight-matched female partner mice for parabiosis were caged together few days before surgery. One day before the surgery the fur from lateral sides of mice was carefully removed with a trimmer followed by depilatory cream (for 3 min) at the site of surgery and excess of fur was removed with a moist gauze pad. The left side partner was shaved on the right side and vice versa. This procedure was performed under isofluorane-inhalation anaesthesia. Mice were fed with food supplemented with Sulfatrim ad libitum one day before surgery. Surgery. Mice were anaesthetized intraperitoneally with 150 mg/kg of ketamine and 15 mg/kg of xylazine. Sterile eye lubricant (Paralube Vet Ointment, 17033-211-38) was applied to both eyes to prevent corneal drying during surgery. Following confirmation that a suitable anaesthetic plane (no response to stimulation) had been attained, mice were placed in a supine position on a surgical tray with heat support provided by a heating pad. The surgical site was cleaned 3 times with cotton swabs soaked in povidone-iodine (Betadine) and then with 70% ethanol. Before surgery, 0.2 ml anaesthetic agent bupivacaine (Marcaine 0.25-0.5% solution) was applied locally. Surgery was performed by a longitudinal skin incision on the lateral side of mice, approximately 0.5 cm above the elbow to 0.5 cm below the knee joint. Mice were laid side-by-side in close contact and the ligaments of the two knees and elbows were sutured together using monofilament non-absorbable suture. Then, the skin incisions were closed by apposing and clipping skin to skin of the pair with 9-mm wound clips. Postoperative procedure. Immediately after surgery, mice were injected subcutaneously with 2 mg/kg meloxicam and 0.5mg/kg buprenorphine and for a maximum of 48 h postoperatively. Mice were provided with Sulfatrim and Hydrogel (clear H 2 O, 70-01-5022) in medicups. Wound clips were removed 14 days after surgery under isofluorane anaesthesia. Parabiosis separation procedure. Mice were anaesthetized and prepared for surgery as indicated above. Mice were separated at the site of parabiosis junction. Using scissors, the skin joining both mice was cut longitudinally. The sutures around the elbows and knees were cut and removed. The resulting wound was closed with 9-mm wound clips. Mice were injected subcutaneously with 2 mg/kg meloxicam and 0.5 mg/kg buprenorphine and for a maximum of 48 h postoperatively. Wound clips were removed 14 days after surgery 42 . Analysis. Bones were prepared for histology on frozen sections as detailed below, and stained with antibodies to detect fluorescent proteins: anti-GFP biotin, anti-RFP (Abcam), fluorescent TRAP staining and TO-PRO-3 as a nuclear stain. Histological sections of 15-μm thickness were scanned by confocal microscopy at 1.5-μm z stacks. Sections were quantified for the number of TRAP + multinuclear cells (more than three nuclei per cell) and YFP and tdTomato expression using Imaris in 3D view and individual z stacks. Pictures of the region of interest (area = 2 mm 2 ) were then generated in .tiff format and analysed by ImageJ software using ROI manager to calculate the mean fluorescence intensity of YFP and tdTomato for individual osteoclasts. For rescue of cathepsin K activity, dissected femurs were fixed in 10% neutral buffered formalin for 24 h. Undecalcified bones were embedded in methyl methacrylate resin, and 7-μm sections were prepared on a rotation microtome. For mineralized bone volume/total volume percentage (BV/TV%), sections were de-plastified and stained with von Kossa reagent (1% silver nitrate/sodium formamide/5% sodium thiosulfate) counterstained with Van Gieson solution. EdU pulse-labelling. Twelve-week-old C57BL/6N mice (Charles River) were injected intraperitoneally with 25 μg/g of 2.5 mg/ml solution of EdU prepared extemporaneously (Fisher C10420, Click-iT EdU Alexa Fluor 488 Flow Cytometry Assay Kit). Blood, bone marrow and bone samples were collected at 60 h and 72 h after injection and bones were prepared for histology of frozen sections as indicated above for adult mice. Histology of frozen sections. Frozen sections were cut at 15-μm thickness using cryofilm and stained overnight with rat anti-tubulin (Abcam, ab6160, 1:200) and with secondary goat anti-rat Alexa Fluor 555 (ThermoFisher Scientific A21430), as described below. Sections were washed 3 times with PBS and stained for EdU using Click-iT EdU Alexa Fluor 488 Imaging Assay Kit (Thermo Fisher Scientific, C10337). Click-it reaction: 357.5 μl of 1× Click-it reaction buffer, 40 μl of CuSO 4 solution (100 mM), 2.5μl of Alexa Fluor 488 azide solution and 100 μl of reaction buffer additive for 500 μl. Sections were incubated for 45 min at room temperature with 100μl of Click-iT EdU reaction buffer then washed with PBS and stained for fluorescent TRAP (ELF 97) and TO-PRO-3 (nuclear stain). Mounting medium was 75% glycerol in PBS. Microscopy. Images were acquired using an inverted Zeiss LSM880 laser scanning confocal microscope. Histological sections of 15-μm thickness were tile-scanned as 1.0-μm z stacks. Analysis. Sections were analysed using Imaris in 3D view and individual z stacks to quantify the percentage of EdU ;Rosa26 LSL-tdTomato were transferred intra-peritoneally at P5, P8 and P11. Mice were killed at P14, 5 days after the last transfer. Bone marrow and blood was analysed for the percentage of chimerism. To enrich Ly6C
Parabiosis. For cellular complementation, female
+ cells the Monocyte Isolation Kit (BM) for mouse (MACS Miltenyi Biotec, 130-100-629) was used as indicated by the manufacturer. Cell numbers of Ly6C + cells were calculated by determining the cell number per ml using a Neubauer chamber in combination with staining for Ly6C analysed by flow cytometry. Bone samples were dissected and prepared for frozen sections as described above and stained for anti-GFP, anti-RFP, fluorescent TRAP and TO-PRO-3. The percentages of YFP + or Tomato + multinuclear cells was quantified in femurs of recipients. Preparation and analysis of bone for histology of paraffin-embedded samples. Bone samples were fixed in 4% formaldehyde (Fisher, 28908) in PBS for 1 day (embryo) or 3 days (postnatal mice) at 4 °C then washed 3 times with PBS and decalcified (for mice older than P7) in a 14% EDTA pH7.1 solution at 4 °C for 5 to 15 days, washed 3 times with PBS and dehydrated in 70% ethanol for 1 day and processed for paraffin sections 43 . Longitudinal sections of femurs were cut at 5-μm thickness using a Leica RM2265 paraffin microtome then place in Superfrost microscope slides, allowed to dry for 48 h and heated in a dry incubator at 65 °C for 1 h, dewaxed and stained for TRAP and haematoxylin.
TRAP-staining protocol. To stain for TRAP, slides were placed in coplin jars and incubated in a 1% (v/v) naphtol-ether substrate solution in basic stock solution for 1 h at 37 °C followed by incubation in a solution containing 2% (v/v) sodium nitrate solution and 2% (v/v) basic fuchsin solution in basic stock solution for 20 min at 37 °C. Slides were rinsed in 3 changes of water then stained with haematoxylin solution (Sigma, GHS332) diluted 1:4 in water for 2 min, washed 3 times with water then dehydrated and mounted in Entellan (Millipore, 107960). Solutions for TRAP staining. Basic stock solution: 0.92% (w/v) anhydrous sodium acetate (Sigma, S8750), 1.14% (w/v) dibasic dihydrate sodium tartrate (Sigma, S4797) and 0.28% (v/v) glacial acetic acid (Sigma, 537020) in distilled water, pH was adjusted between 4.7 and 5.0 with 5 M sodium hydroxide (Fisher, S318-1) . Napthol-ether substrate solution: 2% (w/v) napthol AS-BI phosphate (Sigma, 70482) in 2-ethoxyethanol (Sigma, 256374). Sodium nitrate solution: 4% (w/v) sodium nitrate (Sigma, 237213) in water. Basic fuchsin solution: 5% (w/v) basic fuchsin dye (Sigma, 857343) in 2 N HCL (Fisher, A144-500). Individual images from histological sections of 5-μm thickness were acquired using a Zeiss Axio Laboratory A1 light microscope with a N-Achroplan 2.5×/0.07 M27 (420920-9901) or a N-Achroplan 20×/0.45 M27 (420950-9901) objective. Images were taken in ZEN lite software and exported as .tiff files. Panoramic images were created with the photo-merge tool in Adobe Photoshop CS6. Images of mice were acquired with a dissecting microscope Leica M80 equipped with a Leica IC80 HD camera at 1.0× magnification. The region of interest analysed was the methaphyseal trabecular bone 2 mm below the growth plate. The numbers of TRAP + multinuclear cells (more than three nuclei per cell), associated to bone tissue, were quantified in ImageJ using the cell counter plugin. Numerical values were plotted using GraphPad Prism. Static and dynamic histomorphometry. Young and aged mice were injected intraperitoneally twice with 15 mg/kg body weight calcein (Sigma) dissolved in 1.4% NaHCO 3 in PBS 2 and 3 days apart, respectively. Mice were euthanized two days after the last calcein injection. Femora and tibiae were fixed in 4% PBS-buffered paraformaldehyde and dehydrated in an ascending ethanol series. Subsequently, bones were embedded in methacrylate and cut into 7-μm sections to assess the fluorescent calcein labels. Unstained sections were analysed using fluorescence microscopy to determine the mineralized surface/bone surface, the mineral apposition rate, and the bone formation rate/bone surface. To determine numbers of osteoclasts, bones were decalcified for one week using Osteosoft (Merck), dehydrated and embedded into paraffin. TRAP staining was used to assess the osteoclast surface per bone surface and number of osteoclasts per bone surface. Bone sections were analysed using Osteomeasure software (Osteometrics) following international standards. Preparation of and analysis of bones for immunofluorescence on frozen sections. Samples were prepared as above and after decalcification and washing were soaked in 30% sucrose in PBS at 4 °C for 1-2 days 43 . Tissue samples were placed in disposable histology plastic moulds and embedded in FSC22 Frozen Section Compound Clear (Leica, 3801480) and placed on a flat surface of dry ice and allowed to freeze. Immunofluorescence. Bones were cut at 15-μm thickness using a Cryostat Leica CM3050S with high-profile microtome blades (Leica Surgipath DB80 HS) and cryofilm (Section Laboratory) and allowed to dry for 48 h at 4 °C. Before staining with antibodies, sections were allowed to equilibrate at room temperature for 30 min, rehydrated with PBS (Fisher, 14190) 3 times for 5 min at room temperature. Sections were incubated with blocking buffer containing 0.25% BSA (Fisher BP1600), 10% normal goat serum (Life Technologies, PCN 5000) and 0.3% triton (Sigma, T8787) in PBS for 1 h at room temperature. Sections were washed 2 times with PBS for 5 min. Sections stained with anti-GFP biotin antibody were first incubated with biotin-streptavidin blocking kit (Vector laboratories, SP2002). Streptavidin blocking solution is prepared by adding 4 drops of streptavidin solution to 1 ml PBS/0.25% BSA, samples were incubated for 15 min, then washed once with PBS for 5 min. Biotin blocking solution was prepared by adding 4 drops of biotin solution to 1 ml PBS/0.25% BSA; samples were incubated for 15 min then washed once with PBS for 5 min. Primary and secondary antibodies used are listed in Supplementary Table 2 . Sections were also stained with fluorescent TRAP and nuclear stain. TRAP activity. Sections were prepared for fluorescent TRAP staining by incubating with TRAP incubation solution (112 mM sodium acetate, 76 mM sodium tartate and 11 mM sodium nitrite, pH 4.1-4.3) at room temperature for 10 min. Buffer was removed and incubated with ELF97 substrate (Molecular Probes E6589, 2 mM) at a concentration of 125 μM in TRAP incubation solution for 15 min under UV light and washed 2 times with PBS for 5 min 44 . Nuclear stain used was TO-PRO-3 iodide (Fisher T3605) diluted 1:4,000 in PBS for 5 min. Mounting medium was 75% glycerol in PBS. Images were acquired using an inverted Zeiss LSM880 laser scanning confocal microscope with argon-ion 488 nm, diode 405-30 nm, DPSS 561-10 nm, HeNe 633 nm laser lines and Plan-Apochromat 40×/1.4 N.A. DIC (UV) VIS-IR oil objective. Histological sections of 15-μm thickness were tile-scanned at 1.5-μm z stacks in ZEN black and processed using ZEN lite. Sections were analysed using Imaris in 3D view and individual z stacks to quantify TRAP + multinuclear cells and YFP and tdTomato labelling. Images of the region of interest were generated in .tiff format and analysed by ImageJ software using ROI manager to calculate the MFI of individual osteoclasts. Numerical values were plotted using GraphPad Prism. Animal imaging by computed tomography. NanoSPECT CT. Mice were anaesthetized under isofluorane anaesthesia and placed on an imaging table containing an animal bed equipped with a nosecone for gas inhalation and body temperature stabilization. For three-week-old mice, a mouse bed was used, and for mice eight weeks and older, a rat bed was used. Whole-body imaging of mice was done using a NanoSPECT CT scanner (Mediso) for non-invasive and longitudinal monitoring of the 3D skeletal structure. Each CT scan averaged 15 min and was acquired with an exposure time of 1,000 ms and 240 projections set at a pitch of 1 degree. The tube energy of the X-ray was 55 KVp and 145 μA. The in-plane voxel size was medium generating a voxel size of 147 μm 3 . Reconstructed images were analysed using In vivo Scope 2.0 software (Bioscan). Micro-CT. For 3D X-ray imaging by micro-CT, mice were euthanized and bones placed in 70% ethanol until scanning. Bone microarchitecture was analysed using a vivaCT40 (Scanco Medical). Entire femora or humeri were imaged at a resolution of 10.5 μm (one slice) with an X-ray energy of 70 kVp, 114 mA, and an integration time of 200 ms. The machine was routinely calibrated using hydroxyapatite phantoms for density and geometry. Trabecular bone in femora or humeri from aged mice was assessed in the metaphysis 20 slices below the growth plate using 150 slices. The trabecular region within the cortical bones (P21 mice) was determined in the femoral midshaft (100 slices up, 100 slices down). Pre-defined scripts from Scanco were used for the evaluation. Preparation of tissues and staining for flow cytometry. Yolk sacs from E10.5 embryos were digested for 60 min at 37 °C in PBS containing 5% FCS, collagenase type 4 (Worthington, final concentration 4.2 U/ml) and DNaseI (Sigma-Aldrich, final concentration 100 μg/ml). The digestion reaction was stopped by incubation with 12.5 mM EDTA.
Fetal liver was gently dissociated between the frosted ends of glass slides, and was then digested for 30 min using the same digestion enzyme mix as for yolk sac.
Blood was collected from anaesthetized mice by retro-orbital venous sinus bleeding or cardiac puncture using a 1-ml syringe and a 26G needle rinsed with 100 mM EDTA (Sigma E4884). The collected blood was lysed with 3 ml red blood cell lysis buffer (155 mM NH 4 Cl (Sigma A9434), 10 mM NaHCO 3 (Sigma S5761) and 0.1 mM EDTA (Sigma E4884)) for 5 min, washed with 10 ml FACS buffer (PBS, 0.5% BSA and 2 mM EDTA) and centrifuged at 320g for 7 min at 4 °C. All mice were perfused with 10 ml PBS after blood withdrawal.
Bone marrow cells were collected by crushing or flushing femurs and tibias using a syringe and a 26G needle with 10 ml PBS/5% FCS or RPMI supplemented with 10% FBS. Bone marrow was dissociated by gently pipetting up and down with a 1-ml or 10-ml pipette.
Spleens were gently dispersed between frosted slides and digested for 30 min at 37 °C in PBS with 5% FCS containing collagenase type 4 (Worthington) at a final concentration of 4.2 U/ml and 100 μg/ml DNaseI (Sigma-Aldrich). The reaction was stopped by incubation with 12.5 mM EDTA.
Peritoneal cells were collected by flushing the peritoneal cavity with 10 ml PBS/5% FCS heated to 37 °C. Adult brain and liver were dissected, cut into small fragments and incubated at 37 °C for 30 min in enzyme mix consisting of PBS with 1 mg/ml collagenase D (Sigma, 11088882001), 100 U/ml DNase I (Sigma, DN25), 2.4 mg/ml of dispase (Fisher, 17105-041) and 3% FBS (ThermoFisher Scientific 10438026) or PBS containing 4.2 U/ml collagenase type 4 (Worthington), 100 μg/ml DNaseI, 2.4 mg/ml dispase (Gibco) and 3% FCS at 37 °C for 30 min. After enzyme digestion all tissues were further dissociated by mechanical disruption using 100-μm cell strainers (Falcon, 352360) and a 3-ml syringe plunger in 6-well plates containing 4 ml or 5 ml of cold FACS buffer or PBS/5% FCS. Single-cell suspensions were transferred to 5 ml FACS tubes and pelleted by centrifugation at 320g for 7 min at 4 °C. The cell pellets were resuspended in FACS buffer containing purified antimouse CD16/32 antibody (1:100, Biolegend 101301), 5% normal mouse (Fisher, 015-000-120), 5% normal rat (Fisher 012-000-120) and 5% normal rabbit (Fisher, 011-000-120) serum, and incubated for 10 min on ice or directly stained using blocking antibodies in the staining mixtures. Samples were immunostained with fluorochrome-conjugated antibodies for 30 min on ice, and analysed by flow cytometry using an LSRFortessa or an LSR II (BD-Bioscience). A full list of antibodies for flow cytometry is provided in Supplementary Table 3 . Each sample was stained with Hoechst (ThermoFisher Scientific, Hoechst 33258, 1 μg/ml) or DAPI (Applichem, 1 μg per 25 ml) moments before flow cytometry acquisition.
All analysis was conducted using FlowJo (Tree Star). In all tissues, single live cells were gated by exclusion of dead cells labelled positive by Hoechst or DAPI, side scatter and forward scatter and doublet exclusion using forward-scatter width against forward scatter, as previously described 22,26,27, 45, 46 . To calculate cell numbers per organ or per gram of tissue, organs were weighed, cell suspensions Letter reSeArCH were prepared from a weighed amount (20 to 500 mg) of tissue, and the number of cells per gram of tissue was determined using a cell counter (GUAVA easyCyte HT). Statistical analysis and reproducibility. Data are shown as mean with individual values per mouse represented as dots in graphs, unless stated otherwise. Statistical significance was analysed with GraphPad Prism using unpaired t-tests and two-way ANOVA with Tukey's multiple comparisons test as indicated in the figure legends. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001. n represents the number of biological replicates. Experiments were repeated to ensure reproducibility of the observations. Equal variance was assumed for cell-counting experiments. No statistical methods were used to predetermine sample size. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
Data generated in this study are available from the corresponding author upon reasonable request. The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Sample size
No statistical methods were used to predetermine sample size. For genetic fate-mapping and knockout models at least n=3 mice per group from 2 independent litters were analysed. We ensured that they were similar to those generally employed in the field.
Data exclusions No data was excluded
Replication
All attempts for replication were successful and preformed by multiple investigators. Using independent litters of mice and Cre drivers.
Randomization Male and female littermates were assigned into the control or knockout groups after genotyping
Blinding
The investigators were not blinded to allocation during following experiments and outcome assessment.
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